Michael Vander Hoek

CFO & VP Regulatory at Shuttle Pharmaceuticals

Mr. Vander Hoek serves as the Company's Chief Financial Officer, a position he was appointed to in August 2019, and Vice President, Operations and Regulatory, a position he has held since 2018. Over the past 30, he has held several leadership positions within Georgetown University and MedStar Health, the Georgetown Lombardi Comprehensive Cancer Center's clinical partner and Washington, D.C.'s largest regional health care provider. As Associate Director for Administration from 2007 to 2020, Mr. Vander Hoek managed over 400 faculty scientists, staff and research fellows in the departments of Oncology; Radiation Medicine; Pathology; and Biostatistics, Biomathematics, and Bioinformatics. He also managed a 5-year, $221.9 million institutional commitment to cancer research. Mr. Vander Hoek was Georgetown University’s administrative lead for implementing a $14 million enterprise-wide clinical trial management system in 2017 and was responsible for approval of all cancer clinical trial budgets. Mr. Vander Hoek holds a Master’s in Health Services Administration from The George Washington University, a Bachelor’s in Biology and Psychology from Hope College and completed the Georgetown University Executive Leadership Program in 2018. He served on the Association of American Cancer Institutes’ Finance and Investment Committee during the past decade and the Cancer Center Administrators’ Forum IT Steering Committee.

Links


Org chart